Skip to main content
SpringerLink
Log in

Microbiome

Bacterial strains augment cancer therapeutics

  • News & Views
  • Published:

From Nature Microbiology

View current issue Submit your manuscript

Bifidobacterium bifidum is enriched in the gut microbiome of patients who respond to cancer treatment, but only selected strains of commercial B. bifidum reduced tumour burden synergistically with therapy in a mouse model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Specific B. bifidum strains synergize with cancer therapy.

References

  1. Lee, S.-H. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-020-00831-6 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Routy, B. et al. Science 359, 91–97 (2018).

    Article  CAS  Google Scholar 

  3. Matson, V. et al. Science 359, 104–108 (2018).

    Article  CAS  Google Scholar 

  4. Sun, S. et al. Proc. Natl Acad. Sci. USA 117, 27509–27515 (2020).

  5. Alessandri, G., Ossiprandi, M. C., MacSharry, J., van Sinderen, D. & Ventura, M. Front. Immunol. 10, 2348 (2019).

    Article  CAS  Google Scholar 

  6. Mager, L. F. et al. Science 369, 1481–1489 (2020).

    Article  CAS  Google Scholar 

  7. Shi, Y. et al. J. Exp. Med. 217, e20192282 (2020).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK

    Lindsay J. Hall & Stephen D. Robinson

  2. Chair of Intestinal Microbiome, ZIEL - Institute for Food & Health, School of Life Sciences, Technical University of Munich, Freising, Germany

    Lindsay J. Hall

  3. Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, UK

    Lindsay J. Hall

  4. School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK

    Stephen D. Robinson

Authors
  1. Lindsay J. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen D. Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lindsay J. Hall.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hall, L.J., Robinson, S.D. Bacterial strains augment cancer therapeutics. Nat Microbiol 6, 275–276 (2021). https://doi.org/10.1038/s41564-021-00871-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41564-021-00871-6

  • Springer Nature Limited

Search

Navigation